related ambulatory care visits over a 6 year period. Although all age groups demonstrated an increase in stroke-related visit rates during the study period, the 55-64 year age group had the most significant rise. Among persons aged 55-64 years, stroke-related visit rates increased from 9.1/1000 persons to 39.1/1000 persons (P Trend=<0.0001), resulting in a 428% rise. After adjustment, greater odds of stroke visits were found in persons Ն55 years (55-64 years OR = 3.4, 95%CI: 2.3-5.0; 65-74 years OR = 4.1, 95%CI: 2.7-6.2; Ն75 years OR = 5.4, 95%CI: 3.6-8.2) (age 45-54 referent), blacks (OR = 1.4, 95%CI: 1.0-2.0), men (OR = 1.5, 95%CI: 1.2-1.9), or persons in the South (OR = 1.6, 95%CI: 1.2-2.1). CONCLUSION: From 2000 to 2005, strokerelated ambulatory visits increased significantly in the United States, particularly among the near-elderly, Southern residents, and blacks. These age, regional, and racial disparities in outpatient stroke utilization are not explained by stroke risk factor prevalence. Health care resource allocation needs to target these highrisk groups.
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DU2 DOES COMMUNITY-BASED HEALTH INSURANCE IMPROVE ACCESS TO DRUGS AND HEALTH CARE FOR THE POOREST IN AFRICA?
Souares A 1 , Savadogo G 2 , Gnawali DP 1 , Sauerborn R 1 1 Heidelberg University, Heidelberg, BadenWürttemberg, Germany, 2 Centre de Recherche en Santé de Nouna, Nouna, Kossi, Burkina Faso OBJECTIVES: Health care utilization in Burkina Faso is far below the average level in OECD countries (0.15 and eight contacts per capita and year respectively). Worse still, there is a pronounced income elasticity of demand. Hence, much of the potential benefit of effective drugs remains elusive for most of the sick poor. This paper reports on the enrollment of the poorest quintile in CBI and the change in health care utilization of the insured households. Further more, the effect of a targeted subsidy on enrollment of the poorest 5th of household was assessed. METHODS: Community-based insurance has been offered to a district in Burkina Faso, comprising 74,000 people who lived in 53 villages and the district capital of Nouna since 2004. Community self assessment of poverty was used in 2007 to identify the poorest quintile of households who were subsequently offered insurance at half the usual premium rate. RESULTS: Overall enrollment in health insurance was 5.2% in 2006 and 8.3% in 2007. However, only 1.1% of the poorest quintile of household chose to enroll. In 2007, with the targeted subsidy on enrollment of poorest households, this rate reached 11.1%. Once enrolled, households increased their utilization of health care substantially (from 0.15 to 0.64 contacts per capita and year). This increase in utilization given enrollment held also for the poorest quintile. CONCLUSION: The authors discuss the covariates influencing household decisions to enroll and to use health care subsequently. They stress the need to enhance the access of the poor to drugs and health care in general through the combined effect of community-based insurance and targeted subsidies to the poor.
DU3

CALIFORNIA WILDFIRES AND THEIR IMPACT ON MEDICATION ACQUISITION
Hutchins DS 1 , Liberman JN 2 ,Tong W 1 , Berger JE 3 1 CVS Caremark, Scottsdale, AZ, USA, 2 CVS Caremark Corporation, Hunt Valley, MD, USA, 3 CVS Caremark Inc, Northbrook, IL, USA OBJECTIVE: To explore the impact of the 2007 southern California wildfires on prescription medication access. METHODS: CVS Caremark members living within San Diego, LA/Ventura, Orange, and San Bernardino counties were split into Wildfire (n = 83,479) and non-Wildfire (n = 145,325) cohorts using zip codes with documented wildfire activity between October 20 and November 9, 2007. Weekly pharmacy claims prevalence rates (prevalence) between July 21, and December 8, 2007 (providing 13 pre-, 3 concurrent, and 4 post-wildfire weeks) were derived; calculated as the number of individuals with paid claim(s) divided by all eligible individuals. Cohort-specific prevalence rates were derived for: Analgesics (GPI 64 to 66), anxiolytics (57), antidepressants (58), antihyperlipidemics (39), antihypertensives (36), beta-blockers (33), hypnotics (60), migraine (67), respiratory (41 to 45), anti-ulcer (49), and across all classes. Weekly deviations from cohort-and class-specific 20-week mean prevalence were expressed as percentages. RESULTS: Mean weekly prevalence was 75/1000 for Wildfire and 73/1000 for non-Wildfire cohorts. Overall prevalence was below the mean for both cohorts during the first week of the wildfire period (Wildfire: -12.9%, non-Wildfire: -4.8%); with the Wildfire cohort experiencing decreases approximately four-fold greater than the non-Wildfire cohort in antidepressants, antihyperlipidemics, antihypertensives, two-fold greater in anxiolytics, and similar for all other classes except for the respiratory class, the only class with a prevalence increase relative to the mean (Wildfire: 10.1%, non-Wildfire: 30.8%). During the second week, prevalence increased above the mean in all classes among the Wildfire cohort (4% higher overall) but was mixed for the non-Wildfire cohort (0.9% lower overall). Differences for almost every week before and after the fires were about equal. CONCLUSION: Natural disasters can have a significant affect on access to needed medications. The wildfires in California decreased overall and class-specific medication acquisition during the first week except for respiratory medications. The pharmacy system accommodated these localized emergencies well.
DU4 PRESCRIPTION DRUG UTILIZATION AMONG A NATIONALLY REPRESENTATIVE SAMPLE OF MEDICARE BENEFICIARIES WITH HEART FAILURE
Bain KT 1 , Richardson D 2 , Liao D 2 , Diamond J 3 , Novielli KD 2 , Goldfarb NI 3 1 excelleRx, Inc, Philadelphia, PA, USA, 2 Jefferson Medical College, Philadelphia, PA, USA, 3 Thomas Jefferson University, Philadelphia, PA, USA OBJECTIVE: The efficacy of angiotensin converting-enzyme inhibitors (ACEI), angiotensin II receptor blockers (ARB), betablockers (BB), aldosterone antagonists (AA), digoxin (DG), and diuretics (DU) in reducing morbidity and mortality among persons with heart failure (HF) has been well established in clinical trials. Using the 2002 Medicare Current Beneficiary Survey, we determined utilization of these drugs in the real-world setting among community-dwelling older adults with HF. METHODS: Community-dwelling, non-hospice beneficiaries >65 years of age with a diagnosis code for HF (428.xx) were included. Medication use was determined by beneficiary selfreport, documentation of prescription fills, and computerassisted personal interviews. Diagnosis codes were used to identify beneficiaries without medical contraindications for each drug, who were eligible to receive them. We further classified beneficiaries into groups based on concomitant use of more than one drug: ACEI or ARB and BB (group 1); ACEI or ARB, BB, and AA (group 2); and ACEI or ARB, BB, AA, DG, and DU (group 3). RESULTS: We estimated that 1038, 590, 821, 1059, and 926 survey respondents were eligible to use an ACEI or ARB, BB, AA, DG, or DU, respectively. Among those eligible, 55.9%, 44.1%, Abstracts A19
